Brain natriuretic peptide predicts survival in Chagas' disease more effectively than atrial natriuretic peptide
Open Access
- 1 March 2005
- Vol. 91 (3), 385-387
- https://doi.org/10.1136/hrt.2003.026856
Abstract
Although atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are predictive of left ventricular hypertrophy and dysfunction, they respond differently, for example, to cardiac volume load in fetal circulation or diabetic cardiomyopathy.2 BNP has recently gained increased importance in the clinical diagnosis of cardiovascular diseases, and BNP guided treatment of CHF was found to reduce cardiovascular morbidity.3Keywords
This publication has 4 references indexed in Scilit:
- Pathophysiology of the heart in Chagas' disease: current status and new developmentsCardiovascular Research, 2003
- Fibrosis rather than blood pressure determines cardiac BNP expression in miceRegulatory Peptides, 2003
- Dual natriuretic peptide response to volume load in the fetal circulation.Cardiovascular Research, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000